In the present study, RGS1 was highly expressed in tumor tissues and correlated with shorter overall survival, which also appeared in several previous studies, including multiple myeloma (52), melanoma (53, 54), nonsmall cell lung cancer (55), gastric cancer (56), diffuse large B-cell lymphoma (57), and so on. This evidence concerns the gene RGS1 and melanoma.